JP2007506664A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2007506664A5 JP2007506664A5 JP2006515980A JP2006515980A JP2007506664A5 JP 2007506664 A5 JP2007506664 A5 JP 2007506664A5 JP 2006515980 A JP2006515980 A JP 2006515980A JP 2006515980 A JP2006515980 A JP 2006515980A JP 2007506664 A5 JP2007506664 A5 JP 2007506664A5
- Authority
- JP
- Japan
- Prior art keywords
- formula
- compound
- alkyl
- optionally
- phenyl
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 0 *CNC** Chemical compound *CNC** 0.000 description 1
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| GBGB0314488.8A GB0314488D0 (en) | 2003-06-20 | 2003-06-20 | Therapeutically useful compounds |
| PCT/EP2004/006553 WO2004113279A1 (en) | 2003-06-20 | 2004-06-16 | Inhibitors of matrix metalloproteinase |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2007506664A JP2007506664A (ja) | 2007-03-22 |
| JP2007506664A5 true JP2007506664A5 (cg-RX-API-DMAC7.html) | 2007-07-26 |
Family
ID=27637076
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2006515980A Pending JP2007506664A (ja) | 2003-06-20 | 2004-06-16 | マトリックスメタロプロテイナーゼの阻害剤 |
Country Status (5)
| Country | Link |
|---|---|
| US (2) | US7375248B2 (cg-RX-API-DMAC7.html) |
| EP (1) | EP1636174A1 (cg-RX-API-DMAC7.html) |
| JP (1) | JP2007506664A (cg-RX-API-DMAC7.html) |
| GB (1) | GB0314488D0 (cg-RX-API-DMAC7.html) |
| WO (1) | WO2004113279A1 (cg-RX-API-DMAC7.html) |
Families Citing this family (10)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB0321538D0 (en) * | 2003-09-13 | 2003-10-15 | Glaxo Group Ltd | Therapeutically useful compounds |
| CN101151255B (zh) | 2005-02-22 | 2013-09-11 | 兰贝克赛实验室有限公司 | 5-苯基-戊酸衍生物作为基质金属蛋白酶抑制剂用于治疗哮喘及其它疾病 |
| EP2074093B1 (en) | 2006-08-22 | 2012-10-10 | Ranbaxy Laboratories Limited | Process for preparing matrix metalloproteinase inhibitors and chiral auxiliary therefor |
| US8389500B2 (en) | 2008-10-30 | 2013-03-05 | Gilead Sciences, Inc. | Fused heterocyclic compounds as ion channel modulators |
| CA2785898C (en) * | 2009-12-31 | 2018-07-03 | Viamet Pharmaceuticals, Inc. | Metalloenzyme inhibitor compounds |
| US8916553B2 (en) | 2010-07-26 | 2014-12-23 | Bristol-Myers Squibb Company | Sulfonamide compounds useful as CYP17 inhibitors |
| PH12013500198A1 (en) | 2010-07-30 | 2013-03-11 | Ranbaxy Laboratories Ltd | Matrix metalloproteinase inhibitors |
| CA2812362A1 (en) | 2010-09-24 | 2012-03-29 | Ranbaxy Laboratories Limited | Matrix metalloproteinase inhibitors |
| AU2011306396A1 (en) * | 2010-09-24 | 2013-05-02 | Ranbaxy Laboratories Limited | Matrix metalloproteinase inhibitors |
| EP2926808A1 (en) | 2012-11-28 | 2015-10-07 | Administración General De La Communidad Autónoma De Euskadi | Use of metalloprotease inhibitors for the treatment of polycystic liver diseases |
Family Cites Families (18)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JPS51139626A (en) | 1975-05-29 | 1976-12-02 | Sumitomo Chem Co Ltd | A herbicide and a process for its preparation |
| AT368358B (de) * | 1977-12-24 | 1982-10-11 | Fisons Ltd | Schaedlingsbekaempfungs- und pflanzenwachstumsregulierungsmittel |
| US5852192A (en) | 1992-03-11 | 1998-12-22 | Dr. Karl Thomae Gmbh | Cyclic urea derivatives, pharmaceutical compositions containing these compounds and processes for preparing them |
| US5863949A (en) * | 1995-03-08 | 1999-01-26 | Pfizer Inc | Arylsulfonylamino hydroxamic acid derivatives |
| US5710171A (en) | 1995-05-24 | 1998-01-20 | Merck & Co., Inc. | Bisphenyl inhibitors of farnesyl-protein transferase |
| EP0795550B1 (en) | 1996-03-11 | 2002-06-05 | Sankyo Company Limited | Aniline derivatives having herbicidal activity their preparation and their use |
| EA001561B1 (ru) * | 1996-05-17 | 2001-04-23 | Варнер-Ламберт Компани | Бифенилсульфонамидные ингибиторы матричных металлопротеиназ |
| WO1998009940A1 (en) * | 1996-09-04 | 1998-03-12 | Warner-Lambert Company | Biphenyl butyric acids and their derivatives as inhibitors of matrix metalloproteinases |
| GB9801690D0 (en) * | 1998-01-27 | 1998-03-25 | Pfizer Ltd | Therapeutic agents |
| JPH11236369A (ja) * | 1998-02-23 | 1999-08-31 | Kotobuki Seiyaku Kk | スルホンアミド誘導体及びその製造法並びにこれを含有する医薬組成物 |
| AU757680B2 (en) | 1999-07-01 | 2003-02-27 | Taisho Pharmaceutical Co., Ltd. | Aminobenzoic acid derivatives |
| US6451832B2 (en) | 1999-12-23 | 2002-09-17 | Boehringer Ingelheim Pharma Kg | Benzimidazoles with antithrombotic activity |
| AU4882101A (en) | 2000-04-28 | 2001-11-12 | Shionogi & Co., Ltd. | Mmp-12 inhibitors |
| JP2002205986A (ja) * | 2000-11-08 | 2002-07-23 | Takeda Chem Ind Ltd | ピリミジン誘導体およびそれを含有する除草剤 |
| JP2002193800A (ja) | 2000-12-22 | 2002-07-10 | Taisho Pharmaceut Co Ltd | Ｖｅｇｆ受容体拮抗剤 |
| JP2005504727A (ja) | 2001-04-13 | 2005-02-17 | ベーリンガー インゲルハイム ファーマシューティカルズ インコーポレイテッド | 抗炎症薬として有用なウレア化合物 |
| GB0124928D0 (en) * | 2001-10-17 | 2001-12-05 | Glaxo Group Ltd | Chemical compounds |
| WO2003035610A1 (en) * | 2001-10-26 | 2003-05-01 | Shionogi & Co., Ltd. | Sulfonamide derivative having mmp inhibitory activity |
-
2003
- 2003-06-20 GB GBGB0314488.8A patent/GB0314488D0/en not_active Ceased
-
2004
- 2004-06-16 WO PCT/EP2004/006553 patent/WO2004113279A1/en not_active Ceased
- 2004-06-16 JP JP2006515980A patent/JP2007506664A/ja active Pending
- 2004-06-16 US US10/561,055 patent/US7375248B2/en not_active Expired - Fee Related
- 2004-06-16 EP EP04740011A patent/EP1636174A1/en not_active Withdrawn
-
2008
- 2008-05-19 US US12/122,954 patent/US20080227858A1/en not_active Abandoned